Yueying Liu,Jing Yang,Tyvette S. Hilliard,Zhikun Wang,Jeff Johnson,Wanrui Wang,Elizabeth I. Harper,Connor Ott,Caitlin O’Brien,Leigh Campbell,Brian Crowley,Stephen Grisoli,Nicholas M. Stavrou,Anna Juncker-Jensen,M. Sharon Stack

Abstract:The majority of women with epithelial ovarian cancer (OvCa) are diagnosed with metastatic disease, resulting in a poor 5-year survival of 31%. Obesity is a recognized non-infectious pandemic that increases OvCa incidence, enhances metastatic success and reduces survival. We have previously demonstrated a link between obesity and OvCa metastatic success in a diet-induced obesity mouse model wherein a significantly enhanced tumor burden was associated with a decreased M1/M2 tumor-associated macrophage ratio ( Liu Y et al . Can, Res. 2015; 75:5046–57 ).

Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy